INCY

Incyte Corp

97.69

+2.14+2.24%

After Hours: 96.12 -1.57 -1.61%17:44 04/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE95.76/95.55

TODAY RANGE95.76-97.90

VOL1.52M

MARKET CAP19.44B

52 WEEK RANGE56.13-112.29

AVG VOL (3M)1.71M

% TURNOVER0.76%

TURNOVER--

P/E (TTM)15.24

% RANGE2.24%

EPS(TTM)6.41

P/E(FORWARD)15.74

P/B3.752

BVPS26.04

DIVIDEND--

P/S3.771

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP19.05B

SHARES OUTSTANDING199.01M

NEXT EARNINGS04/27-05/01

FREE FLOAT194.97M

LOT SIZE1

EX-DATE09/01/2000

News

Press Releases

Financial Reports

Profile

Seeking Alpha·15h ago
Stock index futures advance on hopes of U.S.-Iran peace talks
NASDAQ·5d ago
Incyte Now #415 Largest Company, Surpassing Textron
Dow Jones·5d ago
Press Release: Incyte to Report First Quarter Financial Results
Reuters·5d ago
Incyte schedules first-quarter results conference call and webcast
TipRanks·04/07 15:11
Incyte price target raised to $95 from $92 at RBC Capital
Reuters·04/07 11:33
Palvella Therapeutics names Kent Taylor senior vice president of sales
Reuters·04/07 10:24
INCYTE <INCY.O>: RBC RAISES TARGET PRICE TO $95 FROM $92
Seeking Alpha·04/05 13:05
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Seeking Alpha·04/02 16:35
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports
Reuters·04/02 11:01
Adagene, Incyte partner to test muzastotug combo in MSS colorectal cancer trial
Reuters·04/02 11:01
ADAGENE INC - INCYTE TO SPONSOR AND CONDUCT STUDY; ADAGENE TO SUPPLY MUZASTOTUG
TipRanks·04/02 10:57
Incyte (INCY) Receives a Hold from Wells Fargo
Seeking Alpha·04/01 10:22
Stocks hedge funds love
Reuters·03/31 13:04
AI-led selloff in contract research firms may be misjudging disruption risk
TipRanks·03/30 23:08
Incyte Announces Upcoming Resignation of Board Member Schaffert

Same Industry

Name/Symbol

Change%

Price

INCY

MCK

BIIB

Amgen Inc

AMGN

-1.29%

351.02

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-9.29%

0.0898

LLY

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-1.18%

238.46

Abbvie Inc

ABBV

-2.10%

207.94

ZTS

Gilead Sciences Inc

GILD

-2.18%

138.99

Novo-Nordisk A/S

NVO

+0.21%

37.52

Bristol-Myers Squibb Co

BMY

-1.43%

58.62

PFE

Alexion Pharms

ALXN

0.00%

182.50

Sanofi FR

GCVRZ

0.00%

0.8711

Sanofi FR

SNY

-0.68%

46.76

Novartis

NVS

-0.65%

154.05

Dr Reddys Labs

RDY

+0.38%

13.31

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.